Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PSTX | AZN | AMGN | GILD | VRTX |
| Company | Poseida Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.58 | 70.25 | 280.63 | 103.86 | 495.40 |
| High | 9.67 | 70.81 | 284.10 | 106.54 | 498.65 |
| Low | 9.49 | 69.53 | 280.00 | 103.14 | 490.37 |
| Last | 9.50 | 69.93 | 283.09 | 106.34 | 496.49 |
| Change | -0.06 | +0.36 | +2.25 | +3.17 | +2.65 |
| % Change | -0.63% | +0.52% | +0.80% | +3.07% | +0.54% |
| Volume | 21,420,600 | 8,023,400 | 2,082,400 | 9,458,800 | 1,503,400 |
| 20-Day Average Volume | 2,215,435 | 6,971,770 | 3,253,105 | 9,922,935 | 1,725,010 |
| Previous Close | 9.56 | 69.57 | 280.84 | 103.17 | 493.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.48 | 68.61 | 288.99 | 106.37 | 485.76 |
| 20-Day Raw Stochastic | 46.87% | 60.10% | 32.96% | 60.66% | 89.40% |
| 20-Day Relative Strength | 78.00% | 48.56% | 43.80% | 49.73% | 54.51% |
| Weighted Alpha | -2.36 | -9.23 | -10.49 | +59.27 | +20.69 |
| Today's Opinion | 100% Buy | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 16% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 12/30/24 | +4.53% since 04/21/25 | +3.44% since 04/21/25 | +1.93% since 04/21/25 | +3.97% since 04/21/25 |
| Low | 9.39 on 01/03/25 | 66.87 on 04/22/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 480.56 on 04/22/25 |
| High | 9.67 on 01/07/25 | 70.81 on 04/28/25 | 284.10 on 04/28/25 | 107.56 on 04/24/25 | 498.65 on 04/28/25 |
| 1-Month | |||||
| %Chg | +1.50% since 12/06/24 | -5.23% since 03/28/25 | -7.77% since 03/28/25 | -4.88% since 03/28/25 | +0.77% since 03/28/25 |
| Low | 9.35 on 12/09/24 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 9.67 on 01/07/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 502.22 on 04/16/25 |
| 3-Month | |||||
| %Chg | +257.14% since 10/07/24 | +0.49% since 01/28/25 | +1.00% since 01/28/25 | +13.31% since 01/28/25 | +12.66% since 01/28/25 |
| Low | 2.32 on 10/31/24 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 430.81 on 01/29/25 |
| High | 9.67 on 01/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +218.79% since 07/05/24 | -8.00% since 10/28/24 | -10.75% since 10/28/24 | +19.81% since 10/28/24 | +4.22% since 10/28/24 |
| Low | 2.32 on 10/31/24 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 9.67 on 01/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 928,853 | 212,311,376 | 158,279,088 | 133,543,728 | 121,877,672 |
| Shares Outstanding, K | 97,774 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 64,700,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -123,430,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 71,750,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | 20,240,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 1.63 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 11/07/24 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 03/06/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |